Effects of androgens on cardiovascular remodeling

Journal of Endocrinology

Volumn 214, Issue 1, 2012, Pages 1-10

  Ikeda, Yasumasa ^a   Aihara, Ken Ichi ^a   Yoshida, Sumiko ^a   Akaike, Masashi ^b   Matsumoto, Toshio ^a  

^a Graduate School of Health Biosciences   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ANGIOTENSIN II; DOXORUBICIN; ESTROGEN DERIVATIVE;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR EFFECT; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR PERFORMANCE; CARDIOVASCULAR SYSTEM; HEART PROTECTION; HORMONAL REGULATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANDROGENS; ANIMALS; CARDIOVASCULAR DISEASES; HUMANS; MALE; MICE; MICE, KNOCKOUT; MODELS, BIOLOGICAL; RECEPTORS, ANDROGEN; SIGNAL TRANSDUCTION;

EID: 84864295024     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-12-0126     Document Type: Review

References (102)

1. Adams MR, Williams JK & Kaplan JR 1995 Effects of androgens on coronary artery atherosclerosis and atherosclerosis-related impairment of vascular responsiveness. Arteriosclerosis, Thrombosis, and Vascular Biology 15 562-570.
2. Akishita M, Hashimoto M, Ohike Y, Ogawa S, Iijima K, Eto M & Ouchi Y 2007 Low testosterone level is an independent determinant of endothelial dysfunction in men. Hypertension Research 30 1029-1034.
3. Akishita M, Hashimoto M, Ohike Y, Ogawa S, Iijima K, Eto M & Ouchi Y 2010 Low testosterone level as a predictor of cardiovascular events in Japanese men with coronary risk factors. Atherosclerosis 210 232-236.
4. Alexandersen P, Haarbo J, Byrjalsen I, Lawaetz H & Christiansen C 1999 Natural androgens inhibit male atherosclerosis: a study in castrated, cholesterol-fed rabbits. Circulation Research 84 813-819.
5. Anker SD, Chua TP, Ponikowski P, Harrington D, Swan JW, Kox WJ, Poole-Wilson PA & Coats AJ 1997 Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation 96 526-534.
6. Araujo AB, Dixon JM, Suarez EA, Murad MH, Guey LT &Wittert GA 2011 Clinical review: endogenous testosterone and mortality in men: a systematic review and meta-analysis. Journal of Clinical Endocrinology and Metabolism 96 3007-3019.
7. Baltatu O, Cayla C, Iliescu R, Andreev D, Jordan C & Bader M 2002 Abolition of hypertension-induced end-organ damage by androgen receptor blockade in transgenic rats harboring the mouse ren-2 gene. Journal of the American Society of Nephrology 13 2681-2687.
8. Basaria S, Coviello AD, Travison TG, Storer TW, Farwell WR, Jette AM, Eder R, Tennstedt S, Ulloor J, Zhang A et al. 2010 Adverse events associated with testosterone administration. New England Journal of Medicine 363 109-122.
9. Bourghardt J, Wilhelmson AS, Alexanderson C, De Gendt K, Verhoeven G, Krettek A, Ohlsson C & Tivesten A 2010 Androgen receptor-dependent and independent atheroprotection by testosterone in male mice. Endocrinology 151 5428-5437.
10. Burt VL, Cutler JA, Higgins M, Horan MJ, Labarthe D, Whelton P, Brown C & Roccella EJ 1995 Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991. Hypertension 26 60-69.
11. Cai J, Hong Y, Weng C, Tan C, Imperato-McGinley J & Zhu YS 2011 Androgen stimulates endothelial cell proliferation via an androgen receptor/VEGF/cyclin A-mediated mechanism. American Journal of Physiology. Heart and Circulatory Physiology 300 H1210-H1221.
12. Calof OM, Singh AB, Lee ML, Kenny AM, Urban RJ, Tenover JL & Bhasin S 2005 Adverse events associated with testosterone replacement in middleaged and older men: a meta-analysis of randomized, placebo-controlled trials. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 60 1451-1457.
13. Cavasin MA, Sankey SS, Yu AL, Menon S & Yang XP 2003 Estrogen and testosterone have opposing effects on chronic cardiac remodeling and function in mice with myocardial infarction. American Journal of Physiology. Heart and Circulatory Physiology 284 H1560-H1569.
14. Cefalu WT, Pardridge WM, Chaudhuri G & Judd HL 1986 Serum bioavailability and tissue metabolism of testosterone and estradiol in rat salivary gland. Journal of Clinical Endocrinology and Metabolism 63 20-28.
15. Chambon C, Duteil D, Vignaud A, Ferry A, Messaddeq N, Malivindi R, Kato S, Chambon P & Metzger D 2010 Myocytic androgen receptor controls the strength but not the mass of limb muscles. PNAS 107 14327-14332.
16. Chang CS, Kokontis J & Liao ST 1988a Molecular cloning of human and rat complementary DNA encoding androgen receptors. Science 240 324-326.
17. Chang CS, Kokontis J & Liao ST 1988b Structural analysis of complementary DNA and amino acid sequences of human and rat androgen receptors. PNAS 85 7211-7215.
18. Corona G, Monami M, Boddi V, Cameron-Smith M, Fisher AD, de Vita G, Melani C, Balzi D, Sforza A, Forti G et al. 2010 Low testosterone is associated with an increased risk of MACE lethality in subjects with erectile dysfunction. Journal of Sexual Medicine 7 1557-1564.
19. Criqui MH 1986 Epidemiology of atherosclerosis: an updated overview. American Journal of Cardiology 57 18C-23C.
20. Criqui MH, Langer RD, Fronek A, Feigelson HS, Klauber MR, McCann TJ & Browner D 1992 Mortality over a period of 10 years in patients with peripheral arterial disease. New England Journal of Medicine 326 381-386.
21. Ding EL, Song Y, Malik VS & Liu S 2006 Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. Journal of the American Medical Association 295 1288-1299.
22. Dockery F, Rajkumar C, Agarwal S, Waxman J & Bulpitt CJ 2000 Androgen deprivation in males is associated with decreased central arterial compliance and reduced central systolic blood pressure. Journal of Human Hypertension 14 395-397.
23. Dockery F, Bulpitt CJ, Agarwal S, Donaldson M & Rajkumar C 2003 Testosterone suppression in men with prostate cancer leads to an increase in arterial stiffness and hyperinsulinaemia. Clinical Science 104 195-201.
24. Dormandy JA & Rutherford RB 2000 Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). Journal of Vascular Surgery 31 S1-S296.
25. Dunn JF, Nisula BC & Rodbard D 1981 Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma. Journal of Clinical Endocrinology and Metabolism 53 58-68.
26. van Eickels M, Grohe C, Cleutjens JP, Janssen BJ, Wellens HJ & Doevendans PA 2001 17b-Estradiol attenuates the development of pressure-overload hypertrophy. Circulation 104 1419-1423.
27. FanW, Yanase T, Nomura M, Okabe T, Goto K, Sato T, Kawano H, Kato S & Nawata H 2005 Androgen receptor null male mice develop late-onset obesity caused by decreased energy expenditure and lipolytic activity but show normal insulin sensitivity with high adiponectin secretion. Diabetes 54 1000-1008.
28. Fan W, Yanase T, Nishi Y, Chiba S, Okabe T, Nomura M, Yoshimatsu H, Kato S, Takayanagi R & Nawata H 2008 Functional potentiation of leptinsignal transducer and activator of transcription 3 signaling by the androgen receptor. Endocrinology 149 6028-6036.
29. Fernandez-Balsells MM, MuradMH, LaneM, Lampropulos JF, Albuquerque F, Mullan RJ, Agrwal N, Elamin MB, Gallegos-Orozco JF, Wang ATet al. 2010 Clinical review 1: adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis. Journal of Clinical Endocrinology and Metabolism 95 2560-2575.
30. Fogari R, Preti P, Zoppi A, Fogari E, Rinaldi A, Corradi L & Mugellini A 2005 Serum testosterone levels and arterial blood pressure in the elderly. Hypertension Research 28 625-630.
31. Giusti G, Gonnelli P, Borrelli D, Fiorelli G, Forti G, Pazzagli M & Serio M 1975 Age-related secretion of androstenedione, testosterone and dihydrotestosterone by the human testis. Experimental Gerontology 10 241-245.
32. Golden KL, Marsh JD, Jiang Y, Brown T & Moulden J 2003 Gonadectomy of adult male rats reduces contractility of isolated cardiac myocytes. American Journal of Physiology. Endocrinology and Metabolism 285 E449-E453.
33. Grohe C, Kahlert S, Lobbert K, Stimpel M, Karas RH, Vetter H & Neyses L 1997 Cardiac myocytes and fibroblasts contain functional estrogen receptors. FEBS Letters 416 107-112.
34. Grohe C, Kahlert S, Lobbert K & Vetter H 1998 Expression of oestrogen receptor alpha and beta in rat heart: role of local oestrogen synthesis. Journal of Endocrinology 156 R1-R7.
35. Grossmann M 2011 Low testosterone in men with type 2 diabetes: significance and treatment. Journal of Clinical Endocrinology and Metabolism 96 2341-2353.
36. Haddad RM, Kennedy CC, Caples SM, Tracz MJ, Bolona ER, Sideras K, Uraga MV, Erwin PJ & Montori VM 2007 Testosterone and cardiovascular risk in men: a systematic review and meta-analysis of randomized placebocontrolled trials. Mayo Clinic Proceedings 82 29-39.
37. Hall J, Jones RD, Jones TH, Channer KS & Peers C 2006 Selective inhibition of L-type Ca2+ channels in A7r5 cells by physiological levels of testosterone. Endocrinology 147 2675-2680.
38. Hanke H, Lenz C, Hess B, Spindler KD & Weidemann W 2001 Effect of testosterone on plaque development and androgen receptor expression in the arterial vessel wall. Circulation 103 1382-1385.
39. Heinlein CA & Chang C 2002 The roles of androgen receptors and androgenbinding proteins in nongenomic androgen actions. Molecular Endocrinology 16 2181-2187.
40. Horwitz KB & Horwitz LD 1982 Canine vascular tissues are targets for androgens, estrogens, progestins, and glucocorticoids. Journal of Clinical Investigation 69 750-758.
41. Ikeda Y, Aihara K, Sato T, Akaike M, Yoshizumi M, Suzaki Y, Izawa Y, Fujimura M, Hashizume S, Kato M et al. 2005 Androgen receptor gene knockout male mice exhibit impaired cardiac growth and exacerbation of angiotensin II-induced cardiac fibrosis. Journal of Biological Chemistry 280 29661-29666.
42. Ikeda Y, Aihara K, Yoshida S, Sato T, Yagi S, Iwase T, Sumitomo Y, Ise T, Ishikawa K, Azuma H et al. 2009 Androgen-androgen receptor system protects against angiotensin II-induced vascular remodeling. Endocrinology 150 2857-2864.
43. Ikeda Y, Aihara K, Akaike M, Sato T, Ishikawa K, Ise T, Yagi S, Iwase T, Ueda Y, Yoshida S et al. 2010 Androgen receptor counteracts doxorubicininduced cardiotoxicity in male mice. Molecular Endocrinology 24 1338-1348.
44. Jankowska EA, DrohomireckaA, Ponikowska B, WitkowskaA, Lopuszanska M, Szklarska A, Borodulin-Nadzieja L, BanasiakW, Poole-Wilson PA & Ponikowski P 2010 Deficiencies in circulating testosterone and dehydroepiandrosterone sulphate, and depression in men with systolic chronic heart failure. European Journal of Heart Failure 12 966-973.
45. Kalin MF & Zumoff B 1990 Sex hormones and coronary disease: a review of the clinical studies. Steroids 55 330-352.
46. Kawano H, Sato T, Yamada T, Matsumoto T, Sekine K, Watanabe T, Nakamura T, Fukuda T, Yoshimura K, Yoshizawa Tet al. 2003 Suppressive function of androgen receptor in bone resorption. PNAS 100 9416-9421.
47. Khaw KT, Dowsett M, Folkerd E, Bingham S, Wareham N, Luben R, Welch A & Day N 2007 Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) Prospective Population Study. Circulation 116 2694-2701.
48. Kiilavuori K, Naveri H, Leinonen H & Harkonen M 1999 The effect of physical training on hormonal status and exertional hormonal response in patients with chronic congestive heart failure. European Heart Journal 20 456-464.
49. Koizumi H, Yu J, Hashimoto R, Ouchi Y & Okabe T 2010 Involvement of androgen receptor in nitric oxide production induced by icariin in human umbilical vein endothelial cells. FEBS Letters 584 2440-2444.
50. Kontoleon PE, Anastasiou-Nana MI, Papapetrou PD, Alexopoulos G, Ktenas V, Rapti AC, Tsagalou EP & Nanas JN 2003 Hormonal profile in patients with congestive heart failure. International Journal of Cardiology 87 179-183.
51. Kousteni S, Chen JR, Bellido T, Han L, Ali AA, O'Brien CA, Plotkin L, Fu Q, Mancino AT, Wen Y et al. 2002 Reversal of bone loss in mice by nongenotropic signaling of sex steroids. Science 298 843-846.
52. Laughlin GA, Barrett-Connor E & Bergstrom J 2008 Low serum testosterone and mortality in older men. Journal of Clinical Endocrinology and Metabolism 93 68-75.
53. Li Y, Kishimoto I, Saito Y, Harada M, Kuwahara K, Izumi T, Hamanaka I, Takahashi N, Kawakami R, Tanimoto K et al. 2004 Androgen contributes to gender-related cardiac hypertrophy and fibrosis in mice lacking the gene encoding guanylyl cyclase-A. Endocrinology 145 951-958.
54. Lin AL, McGill HC Jr & Shain SA 1981 Hormone receptors of the baboon cardiovascular system. Biochemical characterization of aortic and myocardial cytoplasmic androgen receptors. Circulation Research 49 1010-1016.
55. Losel RM, Falkenstein E, Feuring M, Schultz A, Tillmann HC, Rossol-Haseroth K & Wehling M 2003 Nongenomic steroid action: controversies, questions, and answers. Physiological Reviews 83 965-1016.
56. Losordo DW & Isner JM 2001 Estrogen and angiogenesis: a review. Arteriosclerosis, Thrombosis, and Vascular Biology 21 6-12.
57. Makinen J, Jarvisalo MJ, Pollanen P, Perheentupa A, Irjala K, Koskenvuo M, Makinen J, Huhtaniemi I & Raitakari OT 2005 Increased carotid atherosclerosis in andropausal middle-aged men. Journal of the American College of Cardiology 45 1603-1608.
58. Malhotra A, Buttrick P & Scheuer J 1990 Effects of sex hormones on development of physiological and pathological cardiac hypertrophy in male and female rats. American Journal of Physiology 259 H866-H871.
59. Malkin CJ, Pugh PJ, West JN, van Beek EJ, Jones TH & Channer KS 2006 Testosterone therapy in men with moderate severity heart failure: a doubleblind randomized placebo controlled trial. European Heart Journal 27 57-64.
60. Malkin CJ, Pugh PJ, Morris PD, Asif S, Jones TH & Channer KS 2010 Low serum testosterone and increased mortality in men with coronary heart disease. Heart 96 1821-1825.
61. Marsh JD, Lehmann MH, Ritchie RH, Gwathmey JK, Green GE & Schiebinger RJ 1998 Androgen receptors mediate hypertrophy in cardiac myocytes. Circulation 98 256-261.
62. Martin DS, Biltoft S, Redetzke R & Vogel E 2005 Castration reduces blood pressure and autonomic venous tone in male spontaneously hypertensive rats. Journal of Hypertension 23 2229-2236.
63. Martin-Merino E, Johansson S, Morris T & Garcia Rodriguez LA 2011 Androgen deprivation therapy and the risk of coronary heart disease and heart failure in patients with prostate cancer: a Nested Case-Control Study in UK Primary Care. Drug Safety 34 1061-1077.
64. McCrohon JA, Jessup W, Handelsman DJ & Celermajer DS 1999 Androgen exposure increases human monocyte adhesion to vascular endothelium and endothelial cell expression of vascular cell adhesion molecule-1. Circulation 99 2317-2322.
65. McGill HC Jr, Anselmo VC, Buchanan JM & Sheridan PJ 1980 The heart is a target organ for androgen. Science 207 775-777.
66. Miyamoto J, Matsumoto T, Shiina H, Inoue K, Takada I, Ito S, Itoh J, Minematsu T, Sato T, Yanase T et al. 2007 The pituitary function of androgen receptor constitutes a glucocorticoid production circuit. Molecular and Cellular Biology 27 4807-4814.
67. Mooradian AD, Morley JE & Korenman SG 1987 Biological actions of androgens. Endocrine Reviews 8 1-28.
68. Morano I, Gerstner J, Ruegg JC, Ganten U, Ganten D & Vosberg HP 1990 Regulation of myosin heavy chain expression in the hearts of hypertensive rats by testosterone. Circulation Research 66 1585-1590.
69. Moriyama Y, Yasue H, Yoshimura M, Mizuno Y, Nishiyama K, Tsunoda R, Kawano H, Kugiyama K, Ogawa H, Saito Yet al. 2000 The plasma levels of dehydroepiandrosterone sulfate are decreased in patients with chronic heart failure in proportion to the severity. Journal of Clinical Endocrinology and Metabolism 85 1834-1840.
70. Muller M, van den Beld AW, Bots ML, Grobbee DE, Lamberts SW & van der Schouw YT 2004 Endogenous sex hormones and progression of carotid atherosclerosis in elderly men. Circulation 109 2074-2079.
71. Murabito JM, Evans JC, Larson MG, Nieto K, Levy D & Wilson PW 2003 The ankle-brachial index in the elderly and risk of stroke, coronary disease, and death: the Framingham Study. Archives of Internal Medicine 163 1939-1942.
72. Naito A, Sato T, Matsumoto T, Takeyama K, Yoshino T, Kato S & Ohdera M 2008 Dihydrotestosterone inhibits murine hair growth via the androgen receptor. British Journal of Dermatology 159 300-305.
73. Nettleship JE, Jones TH, Channer KS & Jones RD 2007 Physiological testosterone replacement therapy attenuates fatty streak formation and improves high-density lipoprotein cholesterol in the Tfm mouse: an effect that is independent of the classic androgen receptor. Circulation 116 2427-2434.
74. Ng MK, Quinn CM, McCrohon JA, Nakhla S, Jessup W, Handelsman DJ, Celermajer DS & Death AK 2003 Androgens up-regulate atherosclerosisrelated genes in macrophages from males but not females: molecular insights into gender differences in atherosclerosis. Journal of the American College of Cardiology 42 1306-1313.
75. Nheu L, Nazareth L, Xu GY, Xiao FY, Luo RZ, Komesaroff P & Ling S 2011 Physiological effects of androgens on human vascular endothelial and smooth muscle cells in culture. Steroids 76 1590-1596.
76. Ojeda NB, Grigore D, Yanes LL, Iliescu R, Robertson EB, Zhang H & Alexander BT 2007 Testosterone contributes to marked elevations in mean arterial pressure in adult male intrauterine growth restricted offspring. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 292 R758-R763.
77. Orlic D, Kajstura J, Chimenti S, Limana F, Jakoniuk I, Quaini F, Nadal-Ginard B, Bodine DM, Leri A & Anversa P 2001Mobilized bonemarrow cells repair the infarcted heart, improving function and survival. PNAS 98 10344-10349.
78. Plager JE 1965 The binding of androsterone sulfate, ethiocholanolone sulfate, and dehydroisoandrosterone sulfate by human plasma protein. Journal of Clinical Investigation 44 1234-1239.
79. Price JF, Lee AJ & Fowkes FG 1997 Steroid sex hormones and peripheral arterial disease in the Edinburgh Artery Study. Steroids 62 789-794.
80. Qiu Y, Yanase T, Hu H, Tanaka T, Nishi Y, Liu M, Sueishi K, Sawamura T & Nawata H 2010 Dihydrotestosterone suppresses foam cell formation and attenuates atherosclerosis development. Endocrinology 151 3307-3316.
81. Riggs BL, Khosla S & Melton LJ III 2002 Sex steroids and the construction and conservation of the adult skeleton. Endocrine Reviews 23 279-302.
82. Sato T, Matsumoto T, Yamada T, Watanabe T, Kawano H & Kato S 2003 Late onset of obesity in male androgen receptor-deficient (AR KO) mice. Biochemical and Biophysical Research Communications 300 167-171.
83. Sato T, Matsumoto T, Kawano H, Watanabe T, Uematsu Y, Sekine K, Fukuda T, Aihara K, Krust A, Yamada T et al. 2004 Brain masculinization requires androgen receptor function. PNAS 101 1673-1678.
84. Scragg JL, Jones RD, Channer KS, Jones TH & Peers C 2004 Testosterone is a potent inhibitor of L-type Ca(2+) channels. Biochemical and Biophysical Research Communications 318 503-506.
85. Scragg JL, Dallas ML & Peers C 2007 Molecular requirements for L-type Ca2+ channel blockade by testosterone. Cell Calcium 42 11-15.
86. Sieveking DP, Chow RW & Ng MK 2010a Androgens, angiogenesis and cardiovascular regeneration. Current Opinion in Endocrinology, Diabetes, and Obesity 17 277-283.
87. Sieveking DP, Lim P, Chow RW, Dunn LL, Bao S, McGrath KC, Heather AK, Handelsman DJ, Celermajer DS & Ng MK 2010b A sex-specific role for androgens in angiogenesis. Journal of Experimental Medicine 207 345-352.
88. Simoncini T & Genazzani AR 2003 Non-genomic actions of sex steroid hormones. European Journal of Endocrinology 148 281-292.
89. Smith GD, Shipley MJ & Rose G 1990 Intermittent claudication, heart disease risk factors, and mortality. The Whitehall Study. Circulation 82 1925-1931.
90. Snochowski M, Dahlberg E & Gustafsson JA 1980 Characterization and quantification of the androgen and glucocorticoid receptors in cytosol from rat skeletal muscle. European Journal of Biochemistry 111 603-616.
91. Song D, Arikawa E, Galipeau D, Battell M & McNeill JH 2004 Androgens are necessary for the development of fructose-induced hypertension. Hypertension 43 667-672.
92. Stanworth RD & Jones TH 2009 Testosterone in obesity, metabolic syndrome and type 2 diabetes. Frontiers of Hormone Research 37 74-90.
93. Tharp DL, Masseau I, Ivey J, Ganjam VK & Bowles DK 2009 Endogenous testosterone attenuates neointima formation after moderate coronary balloon injury in male swine. Cardiovascular Research 82 152-160.
94. Tivesten A, Mellstrom D, Jutberger H, Fagerberg B, Lernfelt B, Orwoll E, Karlsson MK, Ljunggren O & Ohlsson C 2007 Low serum testosterone and high serum estradiol associate with lower extremity peripheral arterial disease in elderly men. The MrOS Study in Sweden. Journal of the American College of Cardiology 50 1070-1076.
95. Tivesten A, Vandenput L, Labrie F, Karlsson MK, Ljunggren O, Mellstrom D & Ohlsson C 2009 Low serum testosterone and estradiol predict mortality in elderly men. Journal of Clinical Endocrinology and Metabolism 94 2482-2488.
96. Weinberg EO, Thienelt CD, Katz SE, Bartunek J, Tajima M, Rohrbach S, Douglas PS & Lorell BH 1999 Gender differences in molecular remodeling in pressure overload hypertrophy. Journal of the American College of Cardiology 34 264-273.
97. Wilson JD 1999 The role of androgens in male gender role behavior. Endocrine Reviews 20 726-737.
98. Wilson EM & French FS 1976 Binding properties of androgen receptors. Evidence for identical receptors in rat testis, epididymis, and prostate. Journal of Biological Chemistry 251 5620-5629.
99. Yaron M, Greenman Y, Rosenfeld JB, Izkhakov E, Limor R, Osher E, Shenkerman G, Tordjman K & Stern N 2009 Effect of testosterone replacement therapy on arterial stiffness in older hypogonadal men. European Journal of Endocrinology 160 839-846.
100. Yeap BB, Hyde Z, Almeida OP, Norman PE, Chubb SA, Jamrozik K, Flicker L & Hankey GJ 2009 Lower testosterone levels predict incident stroke and transient ischemic attack in older men. Journal of Clinical Endocrinology and Metabolism 94 2353-2359.
101. Yoshida S, Aihara K, Azuma H, Uemoto R, Sumitomo-Ueda Y, Yagi S, Ikeda Y, Iwase T, Nishio S, Kawano H et al. 2010 Dehydroepiandrosterone sulfate is inversely associated with sex-dependent diverse carotid atherosclerosis regardless of endothelial function. Atherosclerosis 212 310-315.
102. Zhang Y, Stewart KG & Davidge ST 2000 Estrogen replacement reduces age-associated remodeling in rat mesenteric arteries. Hypertension 36 970-974.